Effect of treatment adherence on the association between sex and unfavourable treatment outcomes among tuberculosis patients in Puducherry, India: a mediation analysis.


Journal

Journal of public health (Oxford, England)
ISSN: 1741-3850
Titre abrégé: J Public Health (Oxf)
Pays: England
ID NLM: 101188638

Informations de publication

Date de publication:
14 Jun 2023
Historique:
received: 21 02 2022
revised: 27 04 2022
medline: 19 6 2023
pubmed: 14 6 2022
entrez: 13 6 2022
Statut: ppublish

Résumé

A better understanding of the complex interplay between risk factors of tuberculosis (TB) is essential. This study was part of the Regional Prospective Observational Research for Tuberculosis (RePORT) India consortium and includes newly diagnosed TB patients in Puducherry between 2014 and 2018. We employed mediation analysis to identify the effect of treatment adherence on association between sex and unfavourable TB treatment outcomes. Required demographic and treatment-related variables were extracted from the RePORT India consortium database and causal mediation analysis using parametric regression models was done. Of the 712 TB patients, ~87 (12.2%) had unfavourable TB treatment outcomes. Total effect of male sex was significantly associated with the unfavourable TB treatment outcomes [adjusted odds ratio (aOR) = 2.48; 95% confidence interval (CI): 1.11-5.55]. However, the overall association between male sex and TB treatment outcomes was dominated by the indirect pathway, as the direct pathway does not show significant association (aOR = 1.67; 95% CI: 0.75-3.75), while the indirect pathway shows significantly higher odds of TB treatment outcomes (aOR = 1.48; 95% CI:1.27-1.73), indicating complete mediation by the treatment adherence. The study has shown a complete mediation of sexes through TB treatment adherence for unfavourable treatment outcomes. Developing of treatment strategies require better understanding between the biological and social factors related to TB.

Sections du résumé

BACKGROUND BACKGROUND
A better understanding of the complex interplay between risk factors of tuberculosis (TB) is essential. This study was part of the Regional Prospective Observational Research for Tuberculosis (RePORT) India consortium and includes newly diagnosed TB patients in Puducherry between 2014 and 2018. We employed mediation analysis to identify the effect of treatment adherence on association between sex and unfavourable TB treatment outcomes.
METHODS METHODS
Required demographic and treatment-related variables were extracted from the RePORT India consortium database and causal mediation analysis using parametric regression models was done.
RESULTS RESULTS
Of the 712 TB patients, ~87 (12.2%) had unfavourable TB treatment outcomes. Total effect of male sex was significantly associated with the unfavourable TB treatment outcomes [adjusted odds ratio (aOR) = 2.48; 95% confidence interval (CI): 1.11-5.55]. However, the overall association between male sex and TB treatment outcomes was dominated by the indirect pathway, as the direct pathway does not show significant association (aOR = 1.67; 95% CI: 0.75-3.75), while the indirect pathway shows significantly higher odds of TB treatment outcomes (aOR = 1.48; 95% CI:1.27-1.73), indicating complete mediation by the treatment adherence.
CONCLUSIONS CONCLUSIONS
The study has shown a complete mediation of sexes through TB treatment adherence for unfavourable treatment outcomes. Developing of treatment strategies require better understanding between the biological and social factors related to TB.

Identifiants

pubmed: 35692180
pii: 6605893
doi: 10.1093/pubmed/fdac062
pmc: PMC10273348
doi:

Substances chimiques

Antitubercular Agents 0

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

304-311

Subventions

Organisme : NIH HHS
Pays : United States
Organisme : NIH HHS
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Lancet. 2004 Jan 10;363(9403):157-63
pubmed: 14726171
Clin Infect Dis. 2015 Oct 15;61Suppl 3:S155-9
pubmed: 26409277
Soc Sci Med. 2021 Feb;270:113639
pubmed: 33493956
Infect Dis Poverty. 2017 Dec 15;6(1):167
pubmed: 29241454
Tuberculosis (Edinb). 2018 Mar;109:41-51
pubmed: 29559120
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
BMC Med Res Methodol. 2019 Jan 21;19(1):19
pubmed: 30665353
PLoS One. 2016 Feb 26;11(2):e0150560
pubmed: 26918458
Int J Tuberc Lung Dis. 1999 Oct;3(10):862-8
pubmed: 10524582
PLoS Med. 2016 Sep 06;13(9):e1002119
pubmed: 27598345
Clin Microbiol Infect. 2003 Apr;9(4):289-94
pubmed: 12667238
Health Policy. 2000 May;52(1):33-51
pubmed: 10899643
PLoS One. 2017 Aug 23;12(8):e0183195
pubmed: 28832615
PLoS One. 2019 Mar 27;14(3):e0214011
pubmed: 30917170
BMC Infect Dis. 2017 Aug 15;17(1):567
pubmed: 28806911
Public Health Action. 2017 Dec 21;7(4):299-303
pubmed: 29584792
Eur Respir J. 2021 Aug 19;58(2):
pubmed: 34413124
Soc Sci Med. 1992 Feb;34(3):291-306
pubmed: 1557670
PLoS Med. 2007 Jul 24;4(7):e238
pubmed: 17676945
BMC Med. 2018 Oct 17;16(1):189
pubmed: 30326959
Annu Rev Public Health. 2016;37:17-32
pubmed: 26653405
Tuberc Res Treat. 2016;2016:8608602
pubmed: 27656293
PLoS One. 2018 Nov 20;13(11):e0207491
pubmed: 30458029

Auteurs

Arivarasan Barathi (A)

Department of Preventive and Social Medicine, JIPMER, Puducherry 605006, India.

Yuvaraj Krishnamoorthy (Y)

Department of Preventive and Social Medicine, JIPMER, Puducherry 605006, India.

Pranay Sinha (P)

Section of Infectious Diseases. Boston Medical Center, Boston, MA, USA.

Charles Horsburgh (C)

Department of Epidemiology, Boston University School of Public Health, Boston, MA 02118, USA.

Natasha Hochberg (N)

Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.

Evan Johnson (E)

Department of Medicine and Statistics, Boston University School of Medicine, Boston, MA 02118, USA.

Padmini Salgame (P)

Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 08854, USA.

Soundappan Govindarajan (S)

State TB Cell, Directorate of Health Services, Puducherry 605001, India.

P B Senbagavalli (PB)

Department of Preventive & Social Medicine, JIPMER, Puducherry 605006, India.

Subitha Lakshinarayanan (S)

Department of Preventive and Social Medicine, JIPMER, Puducherry 605006, India.

Gautam Roy (G)

Department of Preventive & Social Medicine, JIPMER, Puducherry 605006, India.

Jerrold Ellner (J)

Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 08854, USA.

Sonali Sarkar (S)

Department of Preventive & Social Medicine, JIPMER, Puducherry 605006, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH